RBI’s New Capital Market Lending Framework: Detailed Analysis of the 2026 Directions

1. Background and Effective Date

The Reserve Bank of India has notified the Reserve Bank of India (Commercial Banks – Credit Facilities) Amendment Directions, 2026 together with amendments to the Reserve Bank of India (Commercial Banks – Concentration Risk Management) Directions, 2025. Collectively referred to as “the Directions”, this package creates a comprehensive and unified regulatory regime for:

  • Acquisition finance provided by banks
  • Lending against a wide spectrum of marketable securities
  • Credit facilities to Capital Market Intermediaries (CMIs)
  • Overall capital market exposure (CME) limits for commercial banks

Effective Date and Transition

  • The Directions take effect from 1 April 2026, or any earlier date on which a bank voluntarily chooses to adopt all provisions.
  • Existing facilities (loans, guarantees, commitments) sanctioned under the old regime can continue till maturity.
  • Any new sanction or renewal after adoption (or after 1 April 2026, whichever is earlier) must comply fully with the new Directions.

The regulatory intent is clear: to provide banks more room to support domestic and outbound M&A and deepen capital markets, but within a calibrated, risk-sensitive framework aligned with broader prudential norms.

2. Rationale and Policy Direction

2.1 Why RBI has reworked the capital market exposure regime

The earlier CME framework was widely perceived as:

  • Fragmented across multiple circulars and product lines
  • Highly prescriptive and restrictive on bank support for M&A
  • Insufficiently aligned with India’s evolving capital markets and outbound investment needs

The new Directions respond to these concerns by:

  1. Formally recognising “acquisition finance” as a product segment and allowing banks to support both domestic and overseas acquisitions by Indian non‑financial companies within clearly defined risk boundaries.
  2. Recasting lending against securities, including equity, listed debt, units of REITs, InvITs and mutual funds, with structured loan‑to‑value (LTV) norms and overarching exposure caps.
  3. Re‑engineering the approach to CMIs, moving towards a principle-based, risk‑sensitive model that still enforces strong collateralisation and anti-speculation safeguards.

2.2 Key regulatory objectives

The Directions aim to:

  • Facilitate strategic consolidation and global expansion by Indian corporates through bank-backed acquisition finance.
  • Boost liquidity and depth in the secondary market for equity, listed debt, REITs, InvITs and mutual funds.
  • Prevent banks from becoming a source of unbridled leverage for speculative trading.
  • Align CME rules with:
    • The large exposure framework
    • Capital adequacy requirements
    • Internal risk management and collateral policies

The result is a consolidated CME definition supported by a 40% of eligible capital base aggregate cap, with 20% sub-limits for direct exposures and for acquisition finance, giving banks more flexibility yet clearer prudential guardrails.

3. Recast Capital Market Exposure (CME) – Scope and Limits

3.1 What is now included in CME?

Under the amended Concentration Risk Management Directions, a bank’s CME combines:

  1. Investment Exposures, including:

    • Direct investments in equity shares and preference shares
    • Convertible bonds and debentures
    • Units of non‑debt mutual fund schemes
    • Units of REITs, InvITs and Alternative Investment Funds

  2. Credit Exposures linked to equity/non‑debt mutual fund risks, such as:

    • Loans to individuals for investments in shares (including IPOs/FPOs/ESOPs), convertible instruments and units of non‑debt mutual funds
    • Any facility where such instruments form primary security or principal collateral
    • All credit facilities to Capital Market Intermediaries
    • Acquisition finance (including financing provided via overseas branches/subsidiaries)
    • Financing extended to non‑debt mutual fund schemes
    • Bridge loans to meet upfront equity contribution in newly formed companies
    • Underwriting commitments in primary issues where proceeds are used for acquisition finance or invested in non‑debt mutual funds
    • Irrevocable payment commitments (IPCs) to clearing corporations
    • Trade exposures as clearing members in equity and commodity derivatives

3.2 Prudential caps – the quantitative overlay

On both solo and consolidated bases:

  • Overall CME cap:

    • Total CME (investment + credit exposure) must not exceed 40% of the bank’s eligible capital base.

  • Direct capital market exposure sub‑limit:

    • Direct investment exposures (such as equity, preference shares, units of non‑debt mutual funds, REITs, InvITs, AIFs) are separately capped at 20% of the eligible capital base.

  • Acquisition finance sub‑limit:

    • Aggregate acquisition finance exposures cannot exceed 20% of the eligible capital base, but must remain within the overall 40% CME ceiling.

Banks may, and in practice likely will, adopt stricter internal limits in line with their own risk appetite and business model.